Your browser doesn't support javascript.
loading
LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation.
Llibre, Alba; López-Macías, Constantino; Marafioti, Teresa; Mehta, Hema; Partridge, Amy; Kanzig, Carina; Rivellese, Felice; Galson, Jacob D; Walker, Lucy J; Milne, Paul; Phillips, Rodney E; Kelly, Dominic F; Freeman, Gordon J; El Shikh, Mohey Eldin; Klenerman, Paul; Willberg, Christian B.
Afiliación
  • Llibre A; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, United Kindgom;
  • López-Macías C; Medical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre "Siglo XXI," Mexican Institute for Social Security, 06720 Mexico City, Mexico;
  • Marafioti T; Department of Histopathology, University College London, London WC1E 6JJ, United Kingdom;
  • Mehta H; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, United Kindgom;
  • Partridge A; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, United Kindgom;
  • Kanzig C; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, United Kindgom;
  • Rivellese F; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom;
  • Galson JD; Oxford Vaccine Group, Department of Paediatrics, National Institute for Health Research, Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7LJ, United Kingdom;
  • Walker LJ; Newcastle University, Newcastle upon Tyne NE1 7RU, United Kingdom;
  • Milne P; Newcastle University, Newcastle upon Tyne NE1 7RU, United Kingdom;
  • Phillips RE; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, United Kindgom;
  • Kelly DF; Oxford Vaccine Group, Department of Paediatrics, National Institute for Health Research, Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7LJ, United Kingdom;
  • Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215; and.
  • El Shikh ME; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom; chris.willberg@ndm.ox.ac.uk m.elshikh@qmul.ac.uk.
  • Klenerman P; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, United Kindgom; Oxford National Institute for Health Research Biomedical Research Centre, Oxford OX3 9DU, United Kingdom.
  • Willberg CB; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, United Kindgom; Oxford National Institute for Health Research Biomedical Research Centre, Oxford OX3 9DU, United Kingdom chris.willberg@ndm.ox.ac.uk m.elshikh@qmul.ac.uk.
J Immunol ; 196(5): 2085-94, 2016 Mar 01.
Article en En | MEDLINE | ID: mdl-26829983
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos B / Activación de Linfocitos / Receptores de Superficie Celular / Centro Germinal / Receptores CXCR4 / Lectinas Tipo C / Subfamilia B de Receptores Similares a Lectina de Células NK Límite: Humans Idioma: En Revista: J Immunol Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos B / Activación de Linfocitos / Receptores de Superficie Celular / Centro Germinal / Receptores CXCR4 / Lectinas Tipo C / Subfamilia B de Receptores Similares a Lectina de Células NK Límite: Humans Idioma: En Revista: J Immunol Año: 2016 Tipo del documento: Article